Laboratorio Banco VidaSeptember 18, 2019

FDA 483 - Laboratorio Banco Vida - September 18, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Laboratorio Banco Vida

Record Details

An FDA inspection of Laboratorio Banco Vida in San Juan, PR, revealed significant deficiencies in their human tissue establishment operations. The firm failed to establish adequate environmental controls, validate aseptic processing, maintain detailed records, and investigate deviations related to positive microbial results. These issues indicate a high risk of contamination and compromise to the quality and safety of umbilical cord blood tissues.

Company: Laboratorio Banco Vida
Inspection Date: September 18, 2019
Product Type: Biologics
Office: Division of Human and Animal Food Operations - East IV
People: Annette Melendez
Irina Gaberman (Investigator)

Open in Dashboard

ID · 2731a493-97b8-4b1f-aa58-3460b8ee8f8c